Novel anticancer agents and targets: recent advances and future perspectives

Area of Science:

• Oncology
• Medicinal Chemistry
• Drug Discovery

Background:

• There is a critical need for novel anticancer agents to improve long-term cancer treatment outcomes.
• Numerous bioactive compounds are undergoing evaluation in clinical and preclinical settings.
• Despite existing heterocyclic anticancer drugs, research continues to identify new therapeutic targets.

Purpose of the Study:

• To provide an overview of emerging anticancer targets.
• To review novel anticancer molecules in early and late-stage clinical and preclinical development.
• To inform the oncology and drug discovery fields about the latest advancements.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of ongoing clinical trials for anticancer agents.
• Examination of preclinical research on novel anticancer targets and molecules.

Main Results:

• Identification of several promising novel anticancer targets.
• Compilation of anticancer molecules progressing through Phase I, II, and III clinical trials.
• Summary of agents in advanced preclinical development.

Conclusions:

• The pipeline for novel anticancer agents and targets is active and promising.
• Continued research into novel targets and molecules is essential for advancing cancer therapy.
• This review offers valuable insights for researchers and clinicians in the field of oncology.